Cargando…
Interaction between Shiga Toxin and Monoclonal Antibodies: Binding Characteristics and in Vitro Neutralizing Abilities
Monoclonal antibodies (MAbs) have been employed either for diagnosis or treatment of infections caused by different pathogens. Specifically for Shiga toxin-producing Escherichia coli (STEC), numerous immunoassays have been developed for STEC diagnosis, showing variability in sensitivity and specific...
Autores principales: | Rocha, Letícia B., Luz, Daniela E., Moraes, Claudia T. P., Caravelli, Andressa, Fernandes, Irene, Guth, Beatriz E. C., Horton, Denise S. P. Q., Piazza, Roxane M. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475226/ https://www.ncbi.nlm.nih.gov/pubmed/23105978 http://dx.doi.org/10.3390/toxins4090729 |
Ejemplares similares
-
Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
por: Luz, Daniela, et al.
Publicado: (2015) -
The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
por: Luz, Daniela, et al.
Publicado: (2021) -
Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay
por: Silva, Miriam A., et al.
Publicado: (2019) -
Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects in vitro and in vivo
por: Luz, Daniela, et al.
Publicado: (2018) -
Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives
por: Henrique, Izabella de Macedo, et al.
Publicado: (2022)